SBFM Sunshine Biopharma posts wider than expected Q4 2025 loss as shares close unchanged for the trading day Is PennantPark PNNT stock worth initiating exposure Q1 2026 Profit Disappoints TACOU Berto leadership lays out key longterm expansion priorities with the release of its latest quarterly earnings report